Find Academic Supervisors

Sunitha Nagrath is a Professor of Chemical Engineering at the University of Michigan, leading the Nagrath Lab. Her research focuses on developing microfluidic and nanotechnology-based tools to isolate and analyze circulating tumor cells (CTCs) and extracellular vesicles (EVs) for cancer diagnostics and personalized medicine. She holds an AIMBE Fellowship and has pioneered technologies like the Graphene Oxide Chip and Microfluidic Labyrinth. Education PhD in Mechanical Engineering, Rensselaer Polytechnic Institute (2004) MS in Nuclear Engineering, Rensselaer Polytechnic Institute (2000) B.Tech in Chemical Engineering, Sri Venkateswara University (1992) Research Interests Her lab integrates engineering, biology, and clinical expertise to study CTCs' role in metastasis, develop high-throughput isolation methods, and leverage exosomes as liquid biopsy biomarkers. Key projects include: CTC-based monitoring of therapy response in lung and pancreatic cancers Microfluidic devices for simultaneous CTC and exosome analysis Functional studies of CTC-derived organoids for drug sensitivity testing Notable Achievements AIMBE Fellow (Junior Faculty, Harvard Medical School/MGH, 2008-2010) Over 150 peer-reviewed publications and patents on CTC/exosome technologies Recipient of the 2021-22 Chemical Engineering Staff Incentive Award (via lab member Mina Zeinali) Labs & Collaborations The Nagrath Lab collaborates with clinicians and engineers to translate technologies like the OncoBean Chip and EVOD chip into clinical settings. Current work emphasizes real-time CTC monitoring and exosome-based immuno-oncology strategies.

• Bio-MEMS and Microfluidics
• Nanotechnology
• Circulating Tumor Cells
• +3 more

Hsueh-Chia Chang is the Bayer Professor of Chemical Engineering in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame's College of Engineering. He also holds a concurrent faculty position in the Department of Aerospace and Mechanical Engineering. As Principal Investigator of the Chang Lab, he leads cutting-edge research in microfluidic and nanofluidic technologies for biomedical applications. Prof. Chang received his B.S. in Chemical Engineering from Caltech in 1976, followed by M.S. and Ph.D. degrees in Chemical Engineering from Princeton University in 1977 and 1980, respectively. His academic journey has established him as a leader in the field of microfluidics and biosensing technologies. Chang's research focuses on developing low-cost liquid biopsy nanotechnologies for cancer screening and therapy management. His lab specializes in microfluidic and nanofluidic research coupled with electrokinetics, optics, plasmonics and acoustics for biosensing applications. Key research areas include Electrokinetics & Biosensing, Optics & Plasmonics, Nanoelectrokinetics, and Droplet Microfluidics. The Chang Lab has developed innovative platforms that can isolate and sort tumor cells, exosomes, microvesicles, lipoproteins, and stress granules from blood samples, then lyse these structures to release RNA/protein biomarkers for detection and quantification. His recent publications reveal a strong focus on extracellular vesicle diagnostics, cancer biomarker detection, and point-of-care diagnostic technologies. The research spans multiple disciplines including oncology, cardiology, and neurology, with applications for pancreatic, liver, breast, ovarian, and lung cancers as well as myocardial infarction diagnosis. Fellow of American Institute of Medical and Biological Engineering (2025) Provost Research Achievement Award, Notre Dame (2024) Fellow of the National Academy of Inventors (2020) Lifetime Achievement Award, American Electrophoresis Society (2019) Fellow of the American Physical Society (1997) Presidential Young Investigator Award, NSF (1985) Prof. Chang has advised over 50 PhD students and postdocs who have gone on to prominent positions in academia and industry. His lab has secured significant funding and has commercialized several technologies through startups like Aopia Biosciences, which launched NanoEx at ISEV 2024. The Chang Lab maintains active collaborations with medical researchers for validating their diagnostic platforms against various cancers and cardiac conditions.

• Microfluidics
• Nanofluidics
• Electrokinetics
• +5 more

Anna Salvati is an Associate Professor specializing in nanomedicine and drug delivery systems. Her research focuses on nanoparticle-cell interactions, biomolecular corona formation, and the physicochemical properties governing nanomaterial behavior in biological environments. Key research themes include cellular uptake mechanisms, toxicity of nanomaterials, and nanoparticle targeting strategies. Recent publications highlight her work on nanoparticle stability, membrane interactions, and environmental impacts of microplastics. Her studies integrate multiomics approaches, advanced imaging, and interlaboratory validation to address challenges in nanomedicine design and safety testing. Current projects explore the role of high-density lipoproteins in nanoparticle functionality and the modulation of drug release kinetics through material engineering.

• Nanomedicine
• Drug Delivery Systems
• Cellular Uptake of Nanoparticles
• +3 more

Dr. Jason Webber is a Senior Lecturer in Biomedical Sciences at Swansea University Medical School. He holds an honorary position as a Research Fellow at Cardiff University and is a board member of the UK Society for Extracellular Vesicles. His research focuses on extracellular vesicles (EVs), particularly their role in cancer progression and as biomarkers for aggressive tumors like prostate cancer. He completed his PhD at Cardiff University's Institute of Nephrology in 2009 and received a Prostate Cancer UK Career Development Fellowship (2014–2020). Dr. Webber's expertise includes EV biology, tumor microenvironment dynamics, and translational research. He actively contributes to teaching modules such as 'Genetics of Cancer' and 'Advanced Research Topics in Biomedical Science'. His work spans collaborations with institutions like Erasmus MC and the CIC bioGUNE in Spain. Key grants include funding for projects like 'Extracellular Vesicle Glycoproteins for Prostate Cancer Diagnosis (EVGlyProD)' and investigations into EV roles in bone metastasis and rare diseases like tuberous sclerosis complex. His research highlights EVs' dual role as functional mediators of tumor growth and potential biomarkers. Notable achievements include demonstrating EV-HSPG's role in stromal activation and developing methodologies for EV-based diagnostics. Dr. Webber supervises multiple PhD and MSc students, emphasizing mentorship in EV research and cancer biology.

• Extracellular Vesicles (EVs)
• Tumour Microenvironment
• Prostate Cancer
• +6 more

R. Kenneth Marcus serves as the Robert Adger Bowen Professor of Chemistry in Clemson University's College of Science Department of Chemistry, where he has maintained an active research program for 38 years. His work bridges analytical instrumentation development and advanced separation science with applications spanning nuclear safeguards to biomedical diagnostics. His academic foundation includes dual Bachelor of Science degrees in Chemistry (with honors) and Physics from Longwood College (1982), followed by a Ph.D. in Chemistry from the University of Virginia (1986). This multidisciplinary training underpins his innovative research approach. Dr. Marcus's research focuses on two synergistic thrusts: (1) plasma-based atomic spectrochemical techniques using glow discharge sources, particularly the liquid sampling-atmospheric pressure glow discharge (LS-APGD) microplasma for optical emission and mass spectrometry; and (2) capillary-channeled polymer (C-CP) fiber stationary phases for high-speed protein and extracellular vesicle separations. Current efforts target field-deployable nuclear safeguards instrumentation and exosome isolation platforms for clinical applications, leveraging commodity polymers like polypropylene and nylon. His 2024-2025 publications reveal a strategic convergence where LS-APGD mass spectrometry enables ultra-high-resolution isotopic analysis for nuclear applications, while C-CP fiber chromatography advances exosome purification across diverse biological matrices. This dual focus positions his work at the intersection of national security needs and emerging biomedical diagnostics. His distinguished recognition includes: Fellow of the Royal Society of Chemistry (2010) Fellow of the American Association for the Advancement of Science (2012) Fellow of the Society for Applied Spectroscopy (2016) Fellow of the National Academy of Inventors (2018) Clemson University Researcher of the Year (2019) South Carolina Governor’s Award for Excellence in Science Research (2001) Dr. Marcus has mentored 44 Ph.D. and 17 M.S. students to completion. His research receives sustained support from the National Nuclear Security Administration (NNSA) through Oak Ridge National Laboratory for nuclear safeguards instrumentation, the National Science Foundation (NSF) for chromatography development, and the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) for metal speciation studies in bioreactors. His laboratory occupies dedicated spaces (BRC 102, 102A, and 106) within Clemson's AG Biotech/Biosystems Research Complex, housing specialized instrumentation for plasma source development, mass spectrometry coupling, and high-throughput fiber chromatography systems that support collaborative work with nuclear security agencies and biomedical researchers.

• Analytical Chemistry
• Atomic Spectroscopy
• Mass Spectrometry
• +7 more

Professor Susan Brooks is a faculty member at Oxford Brookes University in the School of Biological and Medical Sciences . Her research focuses on glycobiology , cancer progression , and the role of extracellular vesicles in metastasis. Professor of Cell Biology Director of Researcher Development Focus on breast and ovarian cancer Specialized in glycosylation mechanisms Research Interests : Dr. Brooks' work explores how aberrant glycosylation of proteins and glycans influences cancer cell behavior, including metastasis and drug resistance . Her recent studies examine extracellular vesicles as diagnostic tools and therapeutic targets. Article Trends : Over 25 years, Dr. Brooks has published 15+ articles on glycosylation patterns in breast and ovarian cancer. Key areas include lectin binding , miRNA regulation , and radiation-induced metastatic changes . Her work bridges cell biology and clinical applications .

• Cancer Biology
• Glycobiology
• Cell Signaling
• +4 more

Carlos Salomon Gallo is a Professor and NHMRC Investigator Fellow (EL2) at The University of Queensland's Centre for Clinical Research, affiliated with the School of Biomedical Sciences. He directs the Centre for Extracellular Vesicle Nanomedicine and leads the Exosome Biology Laboratory. A globally recognized key opinion leader in extracellular vesicles (ranked 3rd worldwide by Expertscape), his research focuses on EV biology for diagnostic and therapeutic applications in ovarian cancer, gestational diabetes, preeclampsia, and other obstetrical syndromes. His research integrates proteomics (SWATH-MS), miRNA analysis, and advanced isolation techniques to develop liquid biopsies. Core interests include: EV biomarker discovery and validation for early disease detection. Mechanisms of EV-mediated signaling in metabolic and oncological pathologies. Engineering EVs for targeted drug delivery and CRISPR-Cas therapeutics. Clinical translation of EV-based diagnostics (IVDs) and therapeutics. Analysis of his recent articles reveals a dominant focus on EV profiling in pregnancy complications (gestational diabetes, preeclampsia) and oncology (ovarian cancer), utilizing multi-omics approaches. Key trends include developing high-sensitivity EV biosensors, understanding hypoxia-induced EV signaling, and exploring 3D models for EV research. He has received significant recognition, including: NHMRC Emerging Leadership Fellow NHMRC Investigator Fellow (EL2) He leads the Exosome Biology Laboratory and the UQ Centre for Extracellular Vesicle Nanomedicine, fostering cross-disciplinary collaboration. His work involves extensive national and international partnerships, evidenced by leadership roles in the Centre for Clinical Diagnostics and over 20 invited international talks in 5 years. He actively mentors HDR students and contributes to global EV research standards (MISEV2023).

• Extracellular Vesicles
• Biomarker Discovery
• Exosome Biology
• +7 more

Dr. Deborah Goberdhan is an Associate Professor at the University of Oxford , affiliated with the Department of Physiology, Anatomy and Genetics (DPAG) . She leads an independent research group investigating amino acid sensing , mTORC1 signaling , and exosome-mediated communication in cancer progression using both human cancer cells and Drosophila models . She serves on the Cancer Research UK Oxford Centre Research Committee , teaches Medical and Biomedical Sciences undergraduates , and acts as Academic Public Engagement Lead for her department. Her research focuses on cell growth regulation through Proton-assisted Amino acid Transporters (PATs) , which function as 'transceptors' modulating mTORC1 activity . This work has expanded to examine exosome heterogeneity and therapeutic delivery mechanisms with support from BBSRC and Cancer Research UK . She co-founded Oxosome , the Oxford extracellular vesicle interest group , to foster interdisciplinary collaboration. Key research areas include Cancer cell communication via exosomes Amino acid signaling in tumor progression Drosophila as cancer model system Clinical collaborations with Prof Adrian L Harris , Prof Freddie C Hamdy , and Prof Clare Verrill Recent publications highlight her group's contributions to exosome biogenesis (2023), brain-targeted siRNA delivery (2021), and nutrient stress responses in cancer (2020). She actively promotes scientific communication through ISEV social media initiatives.

• Cancer Biology
• Cell Growth Regulation
• mTORC1 Signaling
• +5 more

Yong Zeng is an Associate Professor in the Department of Chemistry at the University of Florida. He leads the Zeng Group, focusing on precision medicine through innovative micro/nanoscale technologies. His research bridges chemistry, materials science, bioengineering, and medicine to develop tools for non-invasive cancer and Alzheimer’s disease diagnosis. Key projects include lab-on-a-chip systems, exosome-based liquid biopsy platforms, and CRISPR-driven diagnostic assays. Education: Ph.D., Chemistry, University of Alberta (2007) Postdoctoral Research, University of California, Berkeley (2008-2012) Research Interests: Dr. Zeng’s work centers on creating transformative technologies for precision diagnostics, including nano-engineered microfluidic devices, smart bioanalyzers with AI integration, and exosome-based biomarker analysis. His group has pioneered methods for detecting extracellular vesicles, proteins, nucleic acids, and glycans in blood samples. Awards: 2013 Bioanalysis Young Investigator Award Grants & Collaborations: Supported by NIH grants, his lab collaborates with clinicians and biologists to translate technologies into clinical tools. Notable collaborations include exosome research for precision immunotherapy and liquid biopsy-based cancer diagnosis. Labs/Teams: The Zeng Group operates at the interface of engineering and medicine, emphasizing translational research to bridge laboratory innovations with clinical applications.

• Precision Medicine
• Nanotechnology
• Biomarker Development
• +6 more

Tony Jun Huang is the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke University, with additional professorships in Electrical and Computer Engineering and Biomedical Engineering. His research focuses on acoustofluidics, optofluidics, and micro/nano systems for biomedical diagnostics and therapeutics. Ph.D. in Mechanical and Aerospace Engineering (UCLA, 2005) Huang's research has revolutionized biomedical microsystems through acoustofluidic technologies, enabling contactless particle manipulation, exosome isolation, and advanced diagnostic platforms. His work has been cited over 36,000 times (h-index: 102) with 30 issued/pending patents. Recent publications highlight his innovations in acoustic tweezers, extracellular vesicle analysis, topological acoustofluidics, and AI-assisted biomimetic imaging. His lab develops technologies for single-cell analysis, non-invasive diagnostics, and programmable material systems. 2023 Highly Cited Researcher (Web of Science) 2020 Fellow of the National Academy of Inventors (NAI) 2019 Van C. Mow Medal (ASME) 2017 Analytical Chemistry Young Innovator Award (ACS) 2010 NIH Director's New Innovator Award Huang has taught courses including ME 535: Biomedical Microsystems and mentored numerous graduate students through his Duke Acoustofluidics Lab. His lab's technologies are applied in cancer biomarker detection, Alzheimer's diagnostics, and wound healing hydrogels.

• Acoustofluidics
• Microfluidics
• Lab-on-a-chip
• +3 more

Dr. Yian Yin is an Assistant Professor of Information Science at Cornell University within the Cornell Bowers College of Computing and Information Science. His research focuses on computational social science, data science, and network science to study scientific progress, innovation, and complex social processes. He has affiliations with Northwestern University’s Northwestern Institute on Complex Systems (NICO) and Kellogg Center for Science of Science and Innovation (CSSI). Education: Ph.D. in Industrial Engineering and Management Sciences from Northwestern University Bachelor's degrees in Statistics and Economics from Peking University Research Interests: Computational tools for understanding scientific collaboration and innovation Analysis of policy impacts on scientific output during crises Quantitative frameworks for studying failure in scientific endeavors Cross-disciplinary applications in art, economics, and public health Awards: Forbes 30 Under 30 in Science (2023) Emerging Researcher Award from Complex Systems Society (2023) Advancement Activities: Organized Summer Institute in Computational Social Science (SICSS) Chicago Program Co-Chair for International Conference on Science of Science and Innovation Labs/Teams: Leads computational social science research groups at Cornell, focusing on science-of-science methodologies and innovation ecosystems.

• Computational Social Science
• Data Science
• Network Science
• +5 more

Qun Huo is Professor of Chemistry and Graduate Program Coordinator at the University of Central Florida, with joint appointment in the NanoScience Technology Center. She holds a PhD in Chemistry from University of Miami. Her research develops nanoparticle-based diagnostic technologies for human and animal health. Innovations include rapid immune function tests and exosome analysis platforms using dynamic light scattering techniques. Huo collaborates with medical and veterinary researchers to translate nanotechnology into clinical applications for disease detection and health monitoring.

• Nanodiagnostics
• Biomedical Nanotechnology
• Immunoassays
• +2 more

Professor Ian Johnston is the Director of the Biodetection Technologies Hub and the Wolfson Centre for Biodetection & Instrumentation Research at the University of Hertfordshire. He leads multidisciplinary research in microfluidics, bioaerosol detection, and antimicrobial nanomaterials. His work spans applications in biosecurity, food safety, and environmental monitoring, with collaborations involving UK defense agencies and institutions like the Pirbright Institute and Universities of Cambridge and Bristol. Affiliations: Wolfson Centre for Biodetection, Microfluidics & Microengineering Research Group Education: BSc (Hons) Physics (University of Leeds, 1994), PhD in Microfluidics (University of Hertfordshire) Research interests include digital microfluidics (EWOD), microfluidic lab-on-a-chip devices, and biodetection systems for in-field applications. His projects address biowarfare threats, aquaculture monitoring, and crop protection. Notable collaborations include developing antimicrobial PDMS polymers and electrowetting-enhanced bioaerosol collectors. Over 30 years of expertise in microfluidics and bioaerosol technologies, with notable contributions to droplet actuation systems and rapid pathogen detection platforms. Projects often involve defense and environmental agencies, emphasizing practical, field-ready solutions. Grants & Projects: Leads or co-leads 40+ projects, including CIBD (Compact Biological Detection), Micro-FloTec (flow technology), and bioaerosol sampling innovations. Recent funding spans 2023–2028 with focuses on hydrogel-based sensing and portable biodetection systems.

• Microfluidics
• Biosensing
• Bioaerosols
• +8 more

David Go is the Vice President and Associate Provost for Academic Strategy at the University of Notre Dame, where he also holds the Viola D. Hank Professorship in Aerospace and Mechanical Engineering. He oversees implementation of the University Strategic Framework and manages faculty appointment processes, with administrative oversight of institutes including the Lucy Institute for Data and Society and the Fitzgerald Institute for Real Estate. His research focuses on plasma science, heat transfer, fluid dynamics, and chemical analysis, with significant contributions to plasma-electrochemistry and sustainable chemical synthesis. Education: B.S. (2001) and M.S. (2004) from University of Notre Dame, Ph.D. (2008) from Purdue University His work explores plasma-liquid interfaces, solvated electron dynamics, and plasma-assisted catalysis, particularly for light hydrocarbon conversion. Recent publications highlight advancements in non-aqueous plasma electrolysis, machine learning-enhanced plasma sintering, and interfacial transport phenomena. Awards include the Air Force Young Investigator Award, NSF CAREER award, and multiple honors for teaching and innovation. Current research trends integrate plasma physics with chemical engineering and materials science, focusing on sustainable energy solutions and microscale manufacturing. Scientific recognitions include: Fellow of the American Society of Mechanical Engineers Senior Member of IEEE IEEE Early Achievement Award First-Source Bank Commercialization Award Go has supervised graduate studies and received patents for technologies in plasma-assisted synthesis and microfluidic diagnostics. His leadership roles involve committees addressing academic governance, risk management, and foreign influence in research.

• Plasma Science
• Heat Transfer
• Fluid Dynamics
• +3 more

Kevin Coward is an Associate Professor at the University of Oxford's Nuffield Department of Women's and Reproductive Health (NDWRH), where he serves as Director of Taught Programmes and Lead for Testicular Cryopreservation Research. With expertise in reproductive physiology and endocrinology, he has directed the MSc in Clinical Embryology for 16 years and supervises numerous DPhil students in the fields of male infertility, fertilization mechanisms, and fertility preservation. Dr. Coward earned his BSc and PhD from the University of Stirling before holding post-doctoral positions at several prestigious London institutions. His educational background includes a Postgraduate Diploma in Learning & Teaching in Higher Education from Oxford, where he is a Senior Fellow of the Higher Education Academy and Fellow of the Royal Society of Biology. His research focuses on the molecular mechanisms of oocyte activation at fertilization, particularly the role of sperm-specific phospholipase C (PLCζ) in male infertility. His team investigates how PLCζ relates to conditions such as oocyte activation deficiency and total fertilization failure, while also developing nanoparticle- and exosome-mediated delivery systems for gametes and embryos. A significant aspect of his work involves fertility preservation strategies for prepubertal boys undergoing cancer treatment. Dr. Coward's recent publications demonstrate strong focus on male infertility research methodology, testicular tissue cryopreservation techniques, and the application of nanotechnology in reproductive medicine. His work shows increasing emphasis on developing standardized outcome measures for male infertility research and refining techniques for preserving fertility in young cancer patients. 2019 - Masters Teacher of the Year (FindAMasters and FindAPhD) 2018 & 2017 - Bronze Employer Award for STEM outreach 2018, 2014, 2013 - OxTALENT Awards for teaching innovation 2016 - Finalist, Royal Society of Biology Higher Education Bioscience Teacher of the Year 2015 - University Teaching Excellence Award and Nanoscience Research Leadership Award 2012 - University of Oxford Major Educator Teaching Excellence Award Dr. Coward has supervised 19 DPhil students to completion, 72 MSc students in laboratory settings, and numerous undergraduate and outreach students. His research group has secured funding from diverse sources including The Royal Society, Wellcome Trust, and European Commission. The group collaborates with clinical partners at Oxford University Hospitals NHS Foundation Trust on fertility preservation for young cancer patients. The Coward Research Group, based in the Nuffield Department of Women's and Reproductive Health, maintains active collaborations with The Fertility Partnership (Oxford), University of Dundee, University of Edinburgh, and industry partners like U-Ploid. The group regularly hosts school outreach activities and has won multiple awards for their STEM engagement efforts.

• Male infertility
• Fertilisation
• Oocyte activation
• +7 more